Journals / Retina-Vitreus / 2007 / Cilt: 15 - Sayı: 4

Total antioxidant capacity, total oxidant status and dehydroepiandrosterone sulphate levels in Behcet's disease

Behçet hastalığında toplam antioksidan kapasite, toplam oksidan durum ve dehidroepiandrosteron sülfat düzeyleri

Pages
263–266
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Increased TOD levels and decreased TAC levels indicate increased oxidative stress, which may play a role in the pathogenesis of Behcet’s disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate serum levels of total antioxidant capacity, total oxidant status, and dehydroepiandrosterone sulphate in Behcet’s Disease.
📊
Key Findings & Data:Materials and Methods: Serum samples were taken from 43 patients with Behcet’s disease and 41 age- and sex- matched healthy subjects.
💡
Conclusion & Impact:Conclusion: Increased TOD levels and decreased TAC levels indicate increased oxidative stress, which may play a role in the pathogenesis of Behcet’s disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antioksidanlar · Otoanaliz · Behçet sendromu

Abstract

Purpose: To evaluate serum levels of total antioxidant capacity, total oxidant status, and dehydroepiandrosterone sulphate in Behcet&#8217;s Disease. Materials and Methods: Serum samples were taken from 43 patients with Behcet&#8217;s disease and 41 age- and sex- matched healthy subjects. The levels of TAC and TOS were measured by spectrophotometry and the level of DHEA-S was measured by autoanalyzer. Results: Serum TAC, TOS, and DHEA-S levels were 1.69±0.53 mmol/L, 23.70±20.12 &#956;mol/L, and 208.77±98.71 &#956;g/ dl in the Behcet group, respectively. In the control group, these levels were 2.79±0.39 mmol/L, 14.55±7.90 &#956;mol/L, and 237.08±147.39 &#956;g/dl, respectively. The serum TAC levels were significantly lower (p<0.05) and the serum TOS levels were significantly higher (p<0.05) in the Behcet group compared with the control group. There were no significant differences in DHEA-S levels between the groups (p>0.05). Conclusion: Increased TOD levels and decreased TAC levels indicate increased oxidative stress, which may play a role in the pathogenesis of Behcet&#8217;s disease.

Özet

Amaç: Behçet hastalığında serum toplam antioksidan kapasite (TAK), toplam oksidan durum (TOD) ve dehidroepiandros- teron sülfat (DHEA-S) düzeylerinin değerlendirilmesi. Gereç ve Yöntem: Kırkbeş Behçet hastası ile yaş ve cinsiyet açısından uyumlu 32 sağlıklı bireyden serum örnekleri alındı. TAK ve TOD düzeyleri spektrofotometre ile ölçülür- ken, DHEA-S düzeyi otoanalizör ile ölçüldü. Bulgular: Behçet grubunda serum TAK, TOD ve DHEA-S dü- zeyleri sırasıyla 1.69±0.53 mmol/L, 23.70±20.12 μmol/L ve 208.77±98.71 μg/dl iken kontrol grubunda bu düzey- ler sırasıyla 2.79±0.39 mmol/L, 14.55±7.90 μmol/L ve 237.08±147.39 μg/dl idi. Kontrol grubu ile karşılaştırıldı- ğında Behçet grubunda serum TAK seviyeleri anlamlı ola- rak düşükken (p 0.05). Sonuç: Artmış TOD seviyeleri ve azalmış TAK seviyelerinin gös- terdiği artmış oksidatif stres, Behçet hastalığının patogene- zinde rol oynuyor olabilir.

🔖

Cite This Article

YAĞCI, R., ÖZYURT, H., AKBAŞ, A., AYDIN, B., ÖZLÜK, E., EKŞİOĞLU, M., TOTAN, Y. (2007). Total antioxidant capacity, total oxidant status and dehydroepiandrosterone sulphate levels in Behcet's disease. Retina-Vitreus, Cilt: 15 - Sayı: 4, 263–266. https://ajindex.com/articles/307792

References (16)

  1. Behçet H: Über rezidivierende, apththöse, durch ein virus verur- sachte geschwüre am munt, am auge und an den genitalien. Dermatol Wochenschr 1937;105:1152-1157
  2. Alpsoy E: Behçet hastalığının deri ve mukoza belirtileri. Türkderm Deri Hastalıkları ve Frengi Arşivi 2003;37:92-99
  3. Özbalkan Z, Bilgen Apraş S: Behçet hastalığı. Hacettepe Tıp Der- gisi 2006;37:14-20
  4. Yapislar H, Aydogan S, Borlu M, et al: Decreased nitric oxide and increased platelet aggregation levels in patients with Behcet’s disease. Thromb Res 2007;119:461-465
  5. Yapışlar H, Aydoğan S, Aşçıoğlu Ö: Behçet hastalığında artan oksidatif stresin eritrosit deformabilitesi üzerine olan etkisi. Erciyes Tıp dergisi 2006;28:197-204
  6. Kose K, Yazici C, Cambay N, et al: Lipid peroxidation and eryt- hrocyte antioxidant enzymes in patients with Behcet’s disease. Tohoku J Exp Med 2002;197:9-16
  7. Orem A, Efe H, Deger O, et al: Relationship between lipid pero- xidation and disease activity in patients with Behcet’s disease. J Dermatol Sci 1997;16:11-16
  8. Orem A, Yandi YE, Vanizor B, et al: The evaluation of autoanti- bodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydrope- roxide levels, total antioxidant status, antioxidant enzyme activiti- es, and endothelial dysfunction in patients with Behcet’s disease. Clin Biochem 2002;35:217-224
  9. Saglam K, Serce AF, Yilmaz MI, et al: Trace elements and antio- xidant enzymes in Behcet’s disease. Rheumatol Int 2002;22:93- 96
  10. Bucolo C, Drago F, Lin LR, et al: Neuroactive steroids protect retinal pigment epithelium against oxidative stress. Neuroreport 2005;16:1203-1207
  11. Bastianetto S, Ramassamy C, Poirier J, et al: Dehydroepiandros- terone (DHEA) protects hippocampal cells from oxidative stress- induced damage. Brain Res Mol Brain Res 1999;66:35-41
  12. Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-285
  13. Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-119
  14. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-1111
  15. Demircan G, Dıraman E, Demircan S: Kalp hastalıklarında oksi- datif stresin rolü. Türk Kardiyoloji Derneği Arşivi 2005;33:488- 492
  16. Singal PK, Khaper N, Palace V, et al: The role of ox